PVMIX | VMVAX | PVMIX / VMVAX | |
Total Expense Ratio | 0.69 | 0.07 | 986% |
Annual Report Gross Expense Ratio | 0.75 | 0.07 | 1,071% |
Fund Existence | 22 years | 14 years | - |
Gain YTD | 3.863 | 3.573 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.5B | 29.9B | 8% |
Annual Yield % from dividends | 1.34 | 2.26 | 59% |
Returns for 1 year | -4.56 | 12.14 | -38% |
Returns for 3 years | 6.74 | 28.52 | 24% |
Returns for 5 years | 41.42 | 77.08 | 54% |
Returns for 10 years | 21.00 | 88.11 | 24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRGAX | 39.66 | 0.34 | +0.86% |
iShares Russell 1000 Large-Cap Idx Inv A | |||
JHURX | 34.35 | 0.22 | +0.64% |
JPMorgan Emerging Markets Equity R3 | |||
JFAIX | 39.08 | 0.22 | +0.57% |
JHancock Fundamental All Cap Core R6 | |||
NUGCX | 36.47 | 0.18 | +0.50% |
Nuveen Global Dividend Growth C | |||
LSOFX | 18.91 | 0.08 | +0.42% |
LS Opportunity Fund Institutional Class |